However, after 72 h of treatment with 20 g/ml antiCIL-13 neutralizing antibody, the proliferation of HDLM2 cells (which secrete moderate levels of IL-13) was suppressed to 27% of that of untreated control cells (Fig. a logical objective for future therapeutic Pentostatin strategies. were used as quantitation standards. The hybridization was performed as previously described (7). […]